Entrada Therapeutics | Financial Information

SEC Filings

SEC Filings
Filing date	Form	Description	Filing Group	View
Oct 08, 2021	CORRESP	CORRESP	Other	View HTML 0001104659-21-124695.pdf 0001104659-21-124695.rtf 0001104659-21-124695.xls
Sep 28, 2021	UPLOAD	UPLOAD	Other	View HTML 0000000000-21-011775.pdf 0000000000-21-011775.rtf
Sep 15, 2021	DRS/A	Amendment to a previously filed DRS	Registration Statements	View HTML 0001104659-21-115999.pdf 0001104659-21-115999.rtf 0001104659-21-115999.xls
Sep 02, 2021	UPLOAD	UPLOAD	Other	View HTML 0000000000-21-010725.pdf 0000000000-21-010725.rtf
Aug 06, 2021	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Registration Statements	View HTML 0001104659-21-101417.pdf 0001104659-21-101417.rtf 0001104659-21-101417.xls
Apr 13, 2021	D		Other	View HTML 0001689375-21-000002.pdf 0001689375-21-000002.rtf 0001689375-21-000002.xls
Dec 26, 2019	D/A		Other	View HTML 0001689375-19-000002.pdf 0001689375-19-000002.rtf 0001689375-19-000002.xls
Dec 26, 2018	D		Other	View HTML 0001531209-18-000003.pdf 0001531209-18-000003.rtf 0001531209-18-000003.xls
Nov 10, 2016	D		Other	View HTML 0001689375-16-000002.pdf 0001689375-16-000002.rtf 0001689375-16-000002.xls